CN105596592A - 一种产后护理型中药 - Google Patents
一种产后护理型中药 Download PDFInfo
- Publication number
- CN105596592A CN105596592A CN201610089924.2A CN201610089924A CN105596592A CN 105596592 A CN105596592 A CN 105596592A CN 201610089924 A CN201610089924 A CN 201610089924A CN 105596592 A CN105596592 A CN 105596592A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- chinese medicine
- traditional chinese
- care type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 11
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 11
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 11
- 241000660877 Coridius Species 0.000 claims abstract description 11
- 244000126014 Valeriana officinalis Species 0.000 claims abstract description 10
- 235000013832 Valeriana officinalis Nutrition 0.000 claims abstract description 10
- 235000016788 valerian Nutrition 0.000 claims abstract description 10
- 241000722953 Akebia Species 0.000 claims abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- 235000004347 Perilla Nutrition 0.000 claims abstract description 7
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 7
- 241000109329 Rosa xanthina Species 0.000 claims abstract description 4
- 235000004789 Rosa xanthina Nutrition 0.000 claims abstract description 4
- OEYQBKYISMRWQB-UHFFFAOYSA-N Santal Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 OEYQBKYISMRWQB-UHFFFAOYSA-N 0.000 claims description 16
- 244000020518 Carthamus tinctorius Species 0.000 claims description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 11
- 240000001519 Verbena officinalis Species 0.000 claims description 10
- 235000018718 Verbena officinalis Nutrition 0.000 claims description 10
- 239000006187 pill Substances 0.000 claims description 10
- 244000060924 Brassica campestris Species 0.000 claims description 8
- 235000005637 Brassica campestris Nutrition 0.000 claims description 8
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 8
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 8
- 240000002924 Platycladus orientalis Species 0.000 claims description 8
- 244000292697 Polygonum aviculare Species 0.000 claims description 8
- 235000006386 Polygonum aviculare Nutrition 0.000 claims description 8
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 7
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 7
- 240000007890 Leonurus cardiaca Species 0.000 claims description 7
- 240000000559 Albizia odoratissima Species 0.000 claims description 3
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 3
- 241000220317 Rosa Species 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 23
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 239000011049 pearl Substances 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 240000007185 Albizia julibrissin Species 0.000 abstract 1
- 235000010570 Brassica rapa var. rapa Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 101100149256 Mus musculus Sema6b gene Proteins 0.000 abstract 1
- 244000143396 birdrape Species 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 22
- 230000036407 pain Effects 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 14
- 239000000843 powder Substances 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 11
- 239000000341 volatile oil Substances 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 6
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- -1 n-octyl Chemical group 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000000932 sedative agent Substances 0.000 description 4
- 230000001624 sedative effect Effects 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 229940125725 tranquilizer Drugs 0.000 description 4
- 239000003204 tranquilizing agent Substances 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010037294 Puerperal pyrexia Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- XEYCZVQIOJGCNL-ONEGZZNKSA-N Isoegomaketone Chemical compound CC(C)\C=C\C(=O)C=1C=COC=1 XEYCZVQIOJGCNL-ONEGZZNKSA-N 0.000 description 2
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000000014 Ureteral Calculi Diseases 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000035606 childbirth Effects 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 208000028659 discharge Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- LVHLZMUFIYAEQB-UHFFFAOYSA-N perilla ketone Chemical compound CC(C)CCC(=O)C=1C=COC=1 LVHLZMUFIYAEQB-UHFFFAOYSA-N 0.000 description 2
- XNGKCOFXDHYSGR-UHFFFAOYSA-N perillene Chemical compound CC(C)=CCCC=1C=COC=1 XNGKCOFXDHYSGR-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000005195 poor health Effects 0.000 description 2
- IIQJBVZYLIIMND-UHFFFAOYSA-J potassium;antimony(3+);2,3-dihydroxybutanedioate Chemical compound [K+].[Sb+3].[O-]C(=O)C(O)C(O)C([O-])=O.[O-]C(=O)C(O)C(O)C([O-])=O IIQJBVZYLIIMND-UHFFFAOYSA-J 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- BRHDDEIRQPDPMG-UHFFFAOYSA-N trans-furanoid linalool oxide Natural products CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QWVUOVZJBNQSNS-UHFFFAOYSA-N (+-)-Tropan-3endo,6exo-diol Natural products C1C(O)CC2C(O)CC1N2C QWVUOVZJBNQSNS-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- RANQPHKSRUUPKK-UHFFFAOYSA-N 3-O-[alpha-L-arabinofuranosyl-(1->2)-O-{beta-D-glucopyranosyl-(1->3)}-(alpha-L-arabinopyranosyl)]jujubogenin Natural products CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(CO)C(O)C6O)C(C)(C)C5CCC4(C)C33COC2(C3)O1 RANQPHKSRUUPKK-UHFFFAOYSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- PRUMMFPRJSEJJL-UHFFFAOYSA-N 4-morpholin-4-yl-3-nitroaniline Chemical compound [O-][N+](=O)C1=CC(N)=CC=C1N1CCOCC1 PRUMMFPRJSEJJL-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- YPXWWSJGANMFFQ-AQAMAIGXSA-O Cyanidin 3-O-(6-O-para-coumaroyl)glucoside-5-O-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C1=C2)=CC(O)=CC1=[O+]C(C=1C=C(O)C(O)=CC=1)=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 YPXWWSJGANMFFQ-AQAMAIGXSA-O 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- XEYCZVQIOJGCNL-UHFFFAOYSA-N E-isoegomaketone Natural products CC(C)C=CC(=O)C=1C=COC=1 XEYCZVQIOJGCNL-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- MPYYVGIJHREDBO-UHFFFAOYSA-N Isovaleriansaeure-isobornylester Natural products C1CC2(C)C(OC(=O)CC(C)C)CC1C2(C)C MPYYVGIJHREDBO-UHFFFAOYSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- VELYAQRXBJLJAK-MJSCJBMMSA-N Leonuridine Chemical compound C12C(C)(O)CC(O)C2C=COC1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VELYAQRXBJLJAK-MJSCJBMMSA-N 0.000 description 1
- 241000207925 Leonurus Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- KBVQDUHOYIQWSM-BTVCFUMJSA-N N=C=S.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O Chemical compound N=C=S.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O KBVQDUHOYIQWSM-BTVCFUMJSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 208000021129 Postpartum disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- ZRJLCVQCZVXUFB-QMMMGPOBSA-N Valerianine Chemical compound COCC1=CN=CC2=C1CC[C@@H]2C ZRJLCVQCZVXUFB-QMMMGPOBSA-N 0.000 description 1
- ZRJLCVQCZVXUFB-MRVPVSSYSA-N Valerianine Natural products O(Cc1c2c([C@H](C)CC2)cnc1)C ZRJLCVQCZVXUFB-MRVPVSSYSA-N 0.000 description 1
- BDIAUFOIMFAIPU-KVJIRVJXSA-N Valtratum Chemical compound C([C@]12[C@@H]3C(C(=CO[C@H]3OC(=O)CC(C)C)COC(C)=O)=C[C@@H]1OC(=O)CC(C)C)O2 BDIAUFOIMFAIPU-KVJIRVJXSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical compound C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- NFDFQCUYFHCNBW-SCGPFSFSSA-N dienestrol Chemical compound C=1C=C(O)C=CC=1\C(=C/C)\C(=C\C)\C1=CC=C(O)C=C1 NFDFQCUYFHCNBW-SCGPFSFSSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229930192286 jujuboside Natural products 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- BRHDDEIRQPDPMG-SCZZXKLOSA-N trans-furan linalool oxide Chemical group CC(C)(O)[C@H]1CC[C@](C)(C=C)O1 BRHDDEIRQPDPMG-SCZZXKLOSA-N 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940068146 valepotriate Drugs 0.000 description 1
- BDIAUFOIMFAIPU-UHFFFAOYSA-N valepotriate Natural products CC(C)CC(=O)OC1C=C(C(=COC2OC(=O)CC(C)C)COC(C)=O)C2C11CO1 BDIAUFOIMFAIPU-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药应用领域,特别公开了一种产后护理型中药。该一种产后护理型中药由芸薹子、益母草、西红花、马鞭草、乳香、合欢花、酸枣仁、柏子仁、珍珠、缬草、首乌藤、绞股蓝、甘草、九香虫、梅花、檀香、玫瑰花、预知子和紫苏梗为原料,按照一定的重量配比混合配制而成。本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,有利于病患及时减轻病状。
Description
(一)技术领域
本发明涉及中药应用领域,特别涉及一种产后护理型中药。
(二)背景技术
产后病,也称月子病,月子病是指妇女在生产(包括小产)之后一个月内所受到的外感或内伤而引起的疾患,在月子里没有治愈而留下的病症。妇女在生产后,因筋骨腠理大开,身体虚弱,内外空疏,如果此时不慎使风寒侵入,或大怒大悲,或过多房事,都能引起月子病。临床表现:主要症状有全身肌肉关节麻木、疼痛、酸胀、怕风、怕冷、不耐劳累、屈伸不利为主要表现,严重者每当感受凉风之时就有凉风钻到骨头里的感觉,患者即使在暑热时节其患处也必须裹以厚被或棉衣才能感觉舒适。其症状特征是出凉汗、遇风、遇冷后症状加重,但受累关节和肌肉无红肿等典型的炎症表现。其他表现型尚有身体困乏、心烦急躁,失眠多梦等、部分患者尚有头痛、头晕、眼眶疼痛、眼睛干涩或多泪、视物模糊、体弱多病等征候。产后风湿看上去很象风湿病,但患病关节、肌肉无红肿,血沉、抗链球菌“O”以及产后风湿因子等常见的风湿病化验指标多正常,按常规抗风湿也无效果。此时如果治疗不及时或治疗不当,病邪长期滞留于体内,就会逐渐侵蚀腠理与筋骨经络组织,导致严重的筋骨病或形成难治脏腑病症。病因:一是亡津失血,由于分娩用力、出汗和产伤或失血过多,使阴血骤虚,加之产后调养不慎,以致亡津失血,阳气浮散。二是瘀血内阻,产后元气亏虚,气血无力,气滞血虚;或产后百脉空虚,易感外邪,寒邪乘虚入体,血为寒凝,以导致恶露不畅,留而成瘀;或复因产前即有气郁血滞,以致瘀血内阻;或因产后余血浊液生瘀滞,或胞衣残留或感染邪毒,均可导致瘀血内阻,败血为患。三是外感六淫或饮食房劳所伤,产后气血俱伤,元气受损,正气减弱,即所谓“产后百脉空虚”,因身体虚弱,稍有感触,或产时、产后调理不慎,均可导致脏腑功能失常,变生百病。总之,产后病以“虚”、“瘀”为主,故有“产后多虚多瘀”之说。
(三)发明内容
本发明为了弥补现有技术的不足,提供了一种制备简单、疗效显著的产后护理中药。
本发明是通过如下技术方案实现的:
一种产后护理型中药,由以下重量份数的中药制成:
芸薹子6-15克、益母草6-15克、西红花5-17克、马鞭草6-18克、乳香6-16克、合欢花9-15克、酸枣仁6-14克、柏子仁5-16克、珍珠1-3克、缬草6-19克、首乌藤6-15克、绞股蓝9-15克、甘草8-16克、九香虫6-19克、梅花6-17克、檀香5-17克、玫瑰花6-15克、预知子7-19克、紫苏梗6-15克。
其优选的各原料的重量配比为:
芸薹子6克、益母草6克、西红花5克、马鞭草6克、乳香6克、合欢花9克、酸枣仁6克、柏子仁5克、珍珠1克、缬草6克、首乌藤6克、绞股蓝9克、甘草8克、九香虫6克、梅花6克、檀香5克、玫瑰花6克、预知子7克、紫苏梗6克。
本发明所述中药为散剂、水剂或丸剂,将各种原料清洗干净后,打粉混合,制成散剂、水剂或丸剂定量服用。
其中各原料的药用性能为:
芸薹子:性平,味辛、甘。归肝经、大肠经。活血化瘀、消肿散结、润肠通便。属活血化瘀药下分类的活血调经药。主治产后恶露不尽,瘀血腹痛,痛经,肠风下血,血痢,风湿关节肿痛,痈肿丹毒,乳痈,便秘,粘连性肠梗阻。有抗菌作用,对革兰氏阳性球菌有一定抑制作用,另本品含植物油量多,有润肠通便功效。主要含葡萄糖芜菁芥素、葡萄糖异硫氰酸戊-4-烯-酯、前告伊春,又含脂肪油、蛋白质、芸香苷、菜子固醇、22-去氢菜油固醇及多种氨基酸。
益母草:性微寒,味苦、辛。归肝经、心经、膀胱经。活血调经、利尿消肿。属活血化瘀药分类下的活血调经药。用治妇女血瘀的痛经、闭经、经行不畅、产后瘀阻腹痛;水肿、小便不利等。全草含益母草碱、水苏碱、益母草定及二萜化合物,地上部分含挥发油。具有兴奋子宫、增加冠状动脉流量、改善微循环、扩张外周血管及降低血压等作用,还有利尿及抑制皮肤真菌等作用。
西红花:性平,味甘。归心经、肝经。活血化瘀、凉血解毒、解郁安神。属活血化瘀药分类下的活血调经药。用治经闭、产后瘀阻、温毒发斑、忧郁痞闷、惊悸发狂等。主要含胡萝卜素和苦味素,系其药理活性物质。还含挥发油成分。胡萝卜色素为西红花的主要色素,含量约2%,主要系西红花苷元与各种糖所组成的各种糖苷。苦味素主要为西红花苦素。药理试验证明,本品有兴奋子宫、活血与止血、抗肾炎、抗动脉粥样硬化、抗癌、抗自由基氧化、促进视网膜动脉血流量等作用。
马鞭草:性凉,味苦。归肝经、脾经。活血散瘀、截疟、解毒、利水消肿。属活血化瘀药下属分类的活血调经药。用治癥瘕积聚、经闭痛经、疟疾、喉痹、水肿、热淋。含马鞭草苷、戟叶马鞭草苷、羽扇豆醇、β-谷甾醇、熊果酸、桃叶珊瑚苷,还含咖啡酸。叶中含马鞭草新苷、腺苷及β-胡萝卜素。根茎中含水苏糖。临床用马鞭注射剂治疗疟疾,对控制症状及杀灭疟原虫有一定作用。水煎液有一定镇咳作用,镇咳的有效成分为β-谷甾醇和马鞭草苷。动物实验表明,水及醇提物有消炎、镇痛作用;水煎液及酊剂对白喉杆菌等细菌有较强的抑制作用;对大鼠及人体子宫肌肉均有一定兴奋作用。
乳香:性温,味辛、苦。归心经、脾经、肝经。调气活血、定痛、消肿、生肌。属活血化瘀药下分类的活血止痛药。用治气血瘀滞、心腹疼痛、痈疮肿毒、跌打损伤、风湿痹痛、痛经、产后瘀血刺痛。临床还用于治疗急性阑尾炎。含树脂60%~70%、树胶27%~35%、挥发油3%~8%。树脂主要成分为游离a,B.乳香脂酸、结合乳香脂酸等。挥发油为乳香镇痛的有效成分,主要为具镇痛作用的乙酸正辛酯,占挥发油总量的92.46%。以仪-蒎烯作指标成分,可将索马里乳香与埃塞俄比亚乳香及苏丹乳香鉴别开。
合欢花:性平,味甘。归心经、肝经。解郁安神。属安神药下属分类的养心安神药。用治夜眠不安、抑郁不舒、神经衰弱、食欲不振、跌打损伤、视物不清等症。花中鉴定了25种芳香成分,主要芳香成分为反-芳樟醇氧化物(linalooloxide),芳樟醇(linalool),异戊醇(isopentanol),a-罗勒烯(a-ocimene)和2,2,4-三甲基噁丁烷(2,2,4-trimethylixetane)等。此外,还含矢车菊素-3-葡萄糖甙(cyanidin-3-glucoside)。
酸枣仁:性平,味甘、酸。归肝经、胆经、心经。补肝、宁心、敛汗、生津。属安神药下属分类的养心安神药。水煎服,或入丸散。用治虚烦不眠、惊悸多梦、体虚多汗、津伤口渴。具有镇静催眠、镇静降温、抗惊厥、降压、抗心功能。含脂肪油、挥发油、粘液质、糖分、枣酸、蛋白质、谷甾醇、苦味质、有机酸、维生素C、酸枣仁皂苷、黄酮苷等。并含有植物甾醇、三萜类化合物及GMP活性物质。
柏子仁:性平,味甘。归心经、肾经、大肠经。养心安神、止汗、润肠。属安神药下属分类的养心安神药。用治虚烦失眠、心悸怔忡、阴虚盗汗、肠燥便秘。种子含皂苷、脂肪油及挥发油。还含谷甾醇、柏木醇、红松内酯等化合物。
珍珠:性寒,味甘、咸。归心经、肝经。安神定惊、明目消翳、解毒生肌。属安神药下属分类的重镇安神药。多入丸、散;外用适量,研末撒或点眼。用治惊悸失眠、惊风癫痫、目生云翳、疮疡不敛。主含碳酸钙,并含20余种氨基酸和钠、镁、钾、锶等无机元素。实验表明,珍珠水解液具有延缓衰老作用,可明显减少老龄大鼠SOD活性,减少LPO生成,降低脂褐质的含量;其提取物PFC具有抗氧化作用,可抑制自由基反应,清除体内超氧阴。
缬草:性平,味苦,微甘。归心经、肝经。具有宁心安神的功效。属安神药下属分类的养心安神药。临床多用于治疗神经衰弱、失眠和癔病及其情绪激动。根含挥发油0.5%~2%,油中含异戊酸龙脑酯(bornylisovalerate)、乙酸龙脑酯(bornylacetate)等。另含缬草碱(valerine)、缬草恰碱(chatinine)等生物碱类成分以及缬草素(valepotriatium)等。现代药理实验结果证实了缬草具有镇静安定及降温的作用。此外还证实缬草具有短暂的降压作用和保肝作用。
首乌藤:养心,安神,通络,祛风,治失眠症,劳伤,多汗,血虚身痛,痈疽,瘰疬,风疮疥癣。
绞股蓝:性寒,味苦。归肺经、脾经、肾经。清热解毒、止咳祛痰,并有类似人参的强壮补益作用。属补虚药下分类的补气药。煎服,研末,2.5~3.5克/次,3次/日,10日为一疗程。用治慢性气管炎、支气管哮喘、高脂血症、动脉硬化、肝炎、各种肿瘤、溃疡病及失眠、头痛、白发等。增强免疫功能,可增加机体非特异性免疫的影响,刺激淋巴细胞转化和白介素-2(IL-2)的分泌,可增强体液及细胞免疫及增强自然杀伤细胞的活性,抗肿瘤,延缓衰老,影响脂质代谢,调节心血管系统的功能,对血液系统,具有抑制凝血功能和血小板功能及红细胞聚集性等方面的作用,对中枢神经系统具有明显的抑制作用。可防止地塞米松引起的肾上腺和胸腺萎缩以及血浆皮质醇含量的减少。小鼠灌服水煎剂能明显增强雄鼠睾丸、精囊、脾脏、前列腺和雌鼠子宫的重量,具有雄性和雌性激素样等作用,提高巨噬功能。主要含固醇类、达玛烷型四环三萜皂苷、黄酮类等化学成分,其中有5,24-葫芦二烯醇等成分。
甘草:用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠乏力等。用于胃痛、腹痛及腓肠肌挛急疼痛等,常与芍药同用,能显著增强治挛急疼痛的疗效,如芍药甘草汤。甘草有止咳化痰作用,用于气管炎,肺气肿的病引起的咳嗽痰多,气喘,黏痰不易排出等症。用于痈疽疮疡、咽喉肿痛,湿毒,有抗菌消炎作用。也可用于减少其他中药的解毒作用。用于调和某些药物的烈性。如调味承气汤用本品缓和大黄、芒硝的泻下作用及其对胃肠道的刺激。
九香虫:性温,味辛、咸。归肝经、脾经、肾经。行气止痛、温肾壮阳。属理气药。用治肝胃不和或寒郁中焦所致的胸肋胃脘胀痛以及肾阳不足之腰痛、阳痿。含脂肪、蛋白质、甲壳质等。脂肪中含棕榈酸、硬脂酸、油酸。实验表明,九香虫试管内对金黄色葡萄球菌、伤寒杆菌、甲型副伤寒杆菌和福氏痢疾杆菌有较强抑制作用。其水煎液具有较强的纤溶作用和镇痛作用。九香虫的抗癌、抑癌元素锰和镁含量较高,可能有抗癌作用。
梅花:性平,味微酸。归肝经、胃经、肺经。开郁和中、化痰、解毒。属理气药。用治肝胃气滞所致胁肋胀痛、脘腹痞痛、暖气纳呆、梅核气等。含挥发油,主要有苯甲酸醛、苯甲醇、4-松油烯醇、棕榈酸、苯甲酸和异丁香油酚等,还含有黄酮类化合物芦丁、槲皮素、绿原酸等。
檀香:味辛,性温。归脾经、胃经、心经、肺经。行气温中,开胃止痛。用于寒凝气滞,胸痛,腹痛,胃痛食少;冠心病,心绞痛。
玫瑰花:性温,味甘、微苦。归肝、脾经。行气解郁、和血止痛。属理气药。用治肝胃不和、胁痛脘闷、胃脘胀痛;月经不调、经前乳房胀痛;跌打损伤、瘀肿疼痛等。含挥发油,油中主要成分有β-香茅醇等,此外,还含庚醛、香茅醛等。本品有抗病毒、抗肿瘤、促进大鼠胆汁分泌等作用;还有维生素P样作用;并可解除小鼠口服酒石酸锑钾的毒性反应,同时可使酒石酸锑钾抗血吸虫作用消失。
预知子:性寒,味苦。归肝经、胆经、胃经、膀胱经。疏肝理气、活血止痛、除烦利尿。属理气药。用治肝胃气痛、胃热不思食、腰痛、胁痛、疝气、痛经、子宫下垂、烦渴、输尿管结石。临床与尿珠子同用,治疗输尿管结石有较好疗效。
紫苏梗:性温,味辛。归肺经、脾经。理气宽中、止痛、安胎。属理气药。用治胸膈痞闷、胃脘疼痛、暖气呕吐、胎动不安。含挥发油,油中主要含紫苏醛、1-柠檬烯、α-蒎烯及β-蒎烯、β-丁香烯、α-香柑油烯及芳樟醇等。还含紫苏酮、异白苏烯酮、白苏烯酮、紫苏烯、精氨酸、枯酸、紫苏苷及亚麻酸等。药理实验表明,具孕激素样作用,与孕酮一样能促进子宫内膜腺体的增长。
临床观察:
(1)临床资料
本发明人于2010年至今,对274例产后病患者进行临床观察治疗。
(2)治疗方法
口服,一日三次,水剂每次一剂,散剂、丸剂每次2~5g,饭后服用。根据患者病情轻重计算治疗时间,轻度患者服用3~5天治愈,重病患者连服10~20治愈。
(3)临床结果:
临床治愈215例(78.47%),显效39例(14.23%),有效17例(6.21%),无效3例(1.09%),总有效率为98.91%。
本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,有利于病患及时减轻病状。
(四)具体实施方式
实施例1:
取芸薹子6克、益母草6克、西红花5克、马鞭草6克、乳香6克、合欢花9克、酸枣仁6克、柏子仁5克、珍珠1克、缬草6克、首乌藤6克、绞股蓝9克、甘草8克、九香虫6克、梅花6克、檀香5克、玫瑰花6克、预知子7克、紫苏梗6克,将上述原料清洗干净,打粉混合,制成散剂、水剂或丸剂。
用法用量:口服,一日三次,水剂每次一剂,散剂、丸剂每次2~5g,饭后服用。
实施例2:
取芸薹子15克、益母草15克、西红花17克、马鞭草18克、乳香16克、合欢花15克、酸枣仁14克、柏子仁16克、珍珠3克、缬草19克、首乌藤15克、绞股蓝15克、甘草16克、九香虫19克、梅花17克、檀香17克、玫瑰花15克、预知子19克、紫苏梗15克,将上述原料清洗干净,打粉混合,制成散剂、水剂或丸剂。
用法用量:口服,一日三次,水剂每次一剂,散剂、丸剂每次2~5g,饭后服用。
实施例3:
取芸薹子11克、益母草10克、西红花12克、马鞭草13克、乳香12克、合欢花11克、酸枣仁11克、柏子仁11克、珍珠2克、缬草12克、首乌藤12克、绞股蓝11克、甘草12克、九香虫11克、梅花12克、檀香12克、玫瑰花12克、预知子11克、紫苏梗12克,将上述原料清洗干净,打粉混合,制成散剂、水剂或丸剂。
用法用量:口服,一日三次,水剂每次一剂,散剂、丸剂每次2~5g,饭后服用。
Claims (3)
1.一种产后护理型中药,其特征为,由以下重量份数的中药制成:芸薹子6-15克、益母草6-15克、西红花5-17克、马鞭草6-18克、乳香6-16克、合欢花9-15克、酸枣仁6-14克、柏子仁5-16克、珍珠1-3克、缬草6-19克、首乌藤6-15克、绞股蓝9-15克、甘草8-16克、九香虫6-19克、梅花6-17克、檀香5-17克、玫瑰花6-15克、预知子7-19克、紫苏梗6-15克。
2.根据权利要求1所述的一种产后护理型中药,其特征为,由以下重量份数的中药制成:芸薹子6克、益母草6克、西红花5克、马鞭草6克、乳香6克、合欢花9克、酸枣仁6克、柏子仁5克、珍珠1克、缬草6克、首乌藤6克、绞股蓝9克、甘草8克、九香虫6克、梅花6克、檀香5克、玫瑰花6克、预知子7克、紫苏梗6克。
3.根据权利要求1或2所述的一种产后护理型中药,其特征在于:所述中药为散剂、水剂或丸剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610089924.2A CN105596592A (zh) | 2016-02-18 | 2016-02-18 | 一种产后护理型中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610089924.2A CN105596592A (zh) | 2016-02-18 | 2016-02-18 | 一种产后护理型中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105596592A true CN105596592A (zh) | 2016-05-25 |
Family
ID=55977319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610089924.2A Pending CN105596592A (zh) | 2016-02-18 | 2016-02-18 | 一种产后护理型中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105596592A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106214903A (zh) * | 2016-08-29 | 2016-12-14 | 刘文娟 | 一种产后护理中药组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513484A (zh) * | 2002-12-31 | 2004-07-21 | 魏文利 | 一种用于治疗妇女产后病的中药 |
CN104524211A (zh) * | 2014-12-26 | 2015-04-22 | 王秀花 | 一种产后护理中药 |
CN104888122A (zh) * | 2015-06-12 | 2015-09-09 | 冀庆丽 | 一种治疗产后抑郁症的护理中药 |
-
2016
- 2016-02-18 CN CN201610089924.2A patent/CN105596592A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513484A (zh) * | 2002-12-31 | 2004-07-21 | 魏文利 | 一种用于治疗妇女产后病的中药 |
CN104524211A (zh) * | 2014-12-26 | 2015-04-22 | 王秀花 | 一种产后护理中药 |
CN104888122A (zh) * | 2015-06-12 | 2015-09-09 | 冀庆丽 | 一种治疗产后抑郁症的护理中药 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106214903A (zh) * | 2016-08-29 | 2016-12-14 | 刘文娟 | 一种产后护理中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103893722B (zh) | 一种治疗日光性皮炎的中药组合物及其制备方法 | |
CN101095923B (zh) | 一种治疗宫外孕的中药 | |
CN104173517B (zh) | 治疗原发性三叉神经痛的中药制剂及制备方法 | |
CN103751717B (zh) | 一种治疗痔疮的药物组合物 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN103505530B (zh) | 用于治疗变异性麻疹的中药组合物 | |
CN105596592A (zh) | 一种产后护理型中药 | |
CN105232849A (zh) | 一种治疗烧伤的膏药 | |
CN105362587A (zh) | 一种改善内分泌失调导致的不孕的组合物及其制备方法 | |
CN104815045A (zh) | 一种用于中医针灸的中药方剂及制备方法 | |
CN105727156A (zh) | 抑癌解疼巴布膏及制备方法 | |
CN104069305A (zh) | 一种治疗慢性盆腔炎的中药组合物及其制备方法 | |
CN103356971A (zh) | 一种能够显著提高人体免疫力的中药组合物及其制备方法 | |
CN116870129B (zh) | 一种治疗结缔组织病相关雷诺现象的温经通脉复方中药 | |
CN108186901A (zh) | 一种用于烧烫伤的米蒿复方制剂及其制备方法 | |
CN104622983A (zh) | 治疗直肠炎的中药组合物及其制备方法 | |
CN105596584A (zh) | 一种局部麻醉专用中药制剂及其制备方法 | |
CN112237621A (zh) | 一种用于乳腺增生的中药乳膏及其制备方法 | |
CN104127688A (zh) | 一种中药外用药膏组合物在制备用于预防、缓解和/或治疗骨关节疾病药物中的应用 | |
CN104940684A (zh) | 治疗功能性子宫出血的中药组合物 | |
CN104491151A (zh) | 乳腺结核软坚散结药剂及制备方法 | |
CN114588226A (zh) | 一种治疗骨折的中药组合物及其制备方法 | |
CN113786451A (zh) | 一种用于治疗妇科肿瘤的中药组合物及制备方法 | |
CN109954115A (zh) | 一种用于治疗乳腺增生的外用中药组合物及其制备方法 | |
CN108420954A (zh) | 滋阴清热通淋汤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160525 |